Labcorp Announces Board Changes and Officer Appointments

Ticker: LH · Form: 8-K · Filed: 2024-11-19T00:00:00.000Z

Sentiment: neutral

Topics: governance, officer-appointment, board-changes

TL;DR

Labcorp's board is changing, with new directors and officers appointed. Keep an eye on compensation details.

AI Summary

Labcorp Holdings Inc. announced on November 15, 2024, a change in its board of directors, including the election of new directors and the appointment of certain officers. The filing also disclosed compensatory arrangements for these officers and included a Regulation FD disclosure. Financial statements and exhibits were also filed as part of this report.

Why It Matters

Changes in a company's board and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — The filing primarily concerns routine corporate governance updates and does not indicate any immediate financial distress or significant operational changes.

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates the election of directors and departure of certain officers, but specific names and the exact number of changes are detailed within the full report and exhibits.

Were there any new officer appointments?

Yes, the filing explicitly mentions the appointment of certain officers.

What is the significance of the Regulation FD disclosure?

A Regulation FD disclosure ensures that material non-public information is broadly disseminated to the public, preventing selective disclosure.

What types of financial statements and exhibits were filed?

The filing states that Financial Statements and Exhibits were included, but the specific content of these exhibits would require further examination of the full document.

When was the company incorporated?

The company was incorporated in Delaware.

From the Filing

0000920148-24-000121.txt : 20241119 0000920148-24-000121.hdr.sgml : 20241119 20241119071351 ACCESSION NUMBER: 0000920148-24-000121 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20241115 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241119 DATE AS OF CHANGE: 20241119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LABCORP HOLDINGS INC. CENTRAL INDEX KEY: 0000920148 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 992588107 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11353 FILM NUMBER: 241473367 BUSINESS ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 BUSINESS PHONE: 3362291127 MAIL ADDRESS: STREET 1: 358 S MAIN ST CITY: BURLINGTON STATE: NC ZIP: 27215 FORMER COMPANY: FORMER CONFORMED NAME: LABORATORY CORP OF AMERICA HOLDINGS DATE OF NAME CHANGE: 19950504 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL HEALTH LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19940314 8-K 1 lh-20241115.htm 8-K lh-20241115 November 15, 2024 0000920148 false 0000920148 2024-11-15 2024-11-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C.  20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 November 15, 2024 (Date of earliest event reported) LABCORP HOLDINGS INC. (Exact Name of Registrant as Specified in its Charter) Delaware 1-11353 99-2588107 (State or other jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 358 South Main Street   Burlington, North Carolina 27215 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number including area code) 336 - 229-1127 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Exchange Act. Title of Each Class            Trading Symbol            Name of exchange on which registered Common Stock , $0.10 par value          LH                  New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).                                                      Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors

View on Read The Filing